Nomura Holdings’s AMAG Pharmaceuticals AMAG Stock Holding History

Nomura Holdings’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-70,000	Closed	-$1.06M	–	1481
2018 Q4	$1.06M	Sell	70,000 -80,700	-54%	-$1.54M	﹤0.01%	853
2018 Q3	$3.04M	Buy	+150,700	New	+$3.43M	0.01%	630
2017 Q2	–	Sell	-25,000	Closed	-$562K	–	1666
2017 Q1	$562K	Sell	25,000 -28,424	-53%	-$681K	﹤0.01%	884
2016 Q4	$1.86M	Sell	53,424 -155,454	-74%	-$4.64M	﹤0.01%	883
2016 Q3	$5.13M	Buy	+208,878	New	+$5.22M	0.01%	427
2015 Q3	–	Sell	-10,744	Closed	-$699K	–	2074
2015 Q2	$699K	Buy	10,744 +2,232	+26%	+$140K	﹤0.01%	1140
2015 Q1	$441K	Buy	+8,512	New	+$406K	﹤0.01%	1131
2014 Q1	–	Sell	-18,698	Closed	-$453K	–	2988
2013 Q4	$453K	Buy	18,698 +475	+3%	+$11.2K	﹤0.01%	1329
2013 Q3	$396K	Buy	+18,223	New	+$431K	﹤0.01%	1526

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nomura Holdings's AMAG Position: Q1 2019 in Review

Nomura Holdings sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 70,000 shares — an estimated $1.06M sold.

Nomura Holdings first reported a position in AMAG in Q3 2013 and held it in 9 quarters. The position peaked at $5.13M in Q3 2016. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

Nomura Holdings reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Nomura Holdings sold 70,000 AMAG Pharmaceuticals shares in Q1 2019, an estimated $1.06M.
Nomura Holdings first reported a position in AMAG Pharmaceuticals in Q3 2013 and held it in 9 quarters.
Nomura Holdings's AMAG Pharmaceuticals position peaked at $5.13M in Q3 2016.
166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on Nomura Holdings's 13F filing for Q1 2019, filed 14 May 2019.